The Duke Clinical Vaccine Unit is a consortium of investigators committed to conducting clinical investigations related to the control and prevention of infectious disease with an overarching goal of furthering our understanding of vaccine immune responses and correlates of protection from infection.


October 27, 2015: Duke VTEU Names Valley Fever External Advisory Panel

July 09, 2015: Dr. Emmanuel Walter appointed to the Advisory Committee on Immunization Practices (ACIP).

July 07, 2015: NIH-Funded Vaccine for West Nile Virus Enters Human Clinical Trials

June 19, 2015: Duke Human Vaccine and Treatment Team Awarded Contract of Up to $9 million To Study Fungal Fever

March 23, 2015: Duke VTEU is recruiting healthy adult subjects for a West Nile Virus vaccine study.

January 14, 2015: Duke Clinical Research Institute awarded NIH contract to test new anti-infection drugs.

July 24, 2014: DHVI Quality Assurance Programs Featured in Special Issue of the Journal of Immunological Methods

March 27, 2014:  Dr. Kathyrn Edwards from the Vanderbilt University VTEU will be speaking at the DHVI on Thursday, March 27th.

March 26, 2014: Sallie Permar organizing third talk in colloquia series entitled "Maternal/Infant Vaccination to Prevent Perinatal Infections".

February 27, 2014: Dr. Walter presented a review of vaccine safety concernscomparing live attenuated influenza vaccine to inactivated influenza vaccine in children at the February 26-27, 2014 meeting of the advisory committee on immunization practices (ACIP) at the CDC.


Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules. Libster R, McNeal M, Walter EB, Shane AL, Winkour P, Cress G, Berry AA, Kotloff KL, Sarpong K, Turley CB, Harrison CJ, Pahud BA, Marbin J, Dunn J, El-Khorazaty J, Barrett J, and Edwards KM. Pediactrics 2016 February: 137(2):e20152603.

Maternal benefits of immunization during pregnancy. Swamy GK and Beigi RH. Vaccine. 2015 September 16. pii: S0264-410X(15)01162-7. doi: 10.1016/j.vaccine.2015.08.035.

The Centers for Disease Control and Prevention's public health response to monitoring Tdap safety in pregnant women in the United States. Moro PL, McNeil MM, Sukumaran L, and Broder KR. Human Vaccines & Immunotherapeutics. 2015 November 11:11, doi: 10.1080/21645515.2015.1072664.

Antibody responses among adolescent females receiving the quadrivalent HPV vaccine series corresponding to standard or non-standard dosing intervals. Russell K, Dunne EF, Kemper AR, Dolor RJ, Unger ER, Panicker G, Markowitz LE, Walter EB. Vaccine. 2015 Mar 3. pii: S0264-410X(15)00247-9. doi: 10.1016/j.vaccine.2015.02.058

Maternal immunization: opportunities for scientific advancement. Beigi RH, Fortner KB, Munoz FM, Roberts J, Gordon JL, Han HH, Glenn G, Dormitzer PR, Gu XX, Read JS, Edwards K, Patel SM, Swamy GK. Clin Infect Dis. 2014 Dec 15;59 Suppl 7:S408-14. doi: 10.1093/cid/ciu708. PMID:  25425719
Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices. Frew PM, Saint-Victor DS, Isaacs MB, Kim S, Swamy GK, Sheffield JS, Edwards KM, Villafana T, Kamagate O, Ault K. Clin Infect Dis. 2014 Dec 15;59 Suppl 7:S400-7. doi: 10.1093/cid/ciu726. PMID: 25425718